This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …

This review presents a comprehensive comparative analysis of international guidelines for
managing advanced, non-functioning, well-differentiated pancreatic neuroendocrine tumors …

Gastro-enterohepatic neuroendocrine tumours (GEP-NETs) represent a rare and highly
heterogeneous entity with increasing incidence. Based on the results obtained from several …

Purpose In patients with neuroendocrine tumors (NETs) and liver metastases, increased
gamma-glutamyltransferase (GGT) is commonly assumed as an indicator for progressive …

Everolimus and peptide receptor radionuclide therapy (PRRT, 177Lu-DOTATATE) are 2
treatments recommended in guidelines for gastroenteropancreatic metastatic …

Neuroendocrine neoplasms are a diverse group of neoplasms that can occur in various
areas throughout the body. Well‐differentiated neuroendocrine tumors (NETs) most often …

Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging
diagnosis and clinical management. Their incidence and prevalence continue to rise mainly …

Neuroendocrine neoplasms (NENs) comprise a beautifully complicated, exciting landscape
of histologies and clinical behaviors. However, the nuanced complexity of low-and high …

Importance Evidence-based treatment decisions for advanced gastroenteropancreatic
neuroendocrine neoplasms (GEP-NENs) require individualized patient-centered decision …

Simple Summary Many patients diagnosed with gastroenteropancreatic neuroendocrine
tumors present with metastatic disease at the time of diagnosis. As many as 20% of patients …